Filter by
Selections
September 11, 2015
Arrowhead Nominates ARC-HIF2 As First RNAi Therapeutic Candidate Using Extrahepatic DPC™ Delivery System
Read MoreSeptember 10, 2015
Arrowhead to Webcast Analyst Day Presentation on Hepatitis B Candidate ARC-520
Read MoreJuly 8, 2015
Arrowhead Receives Regulatory Clearance for ARC-AAT Phase 1 in the United Kingdom and New Zealand
Read MoreJuly 2, 2015